A carregar...
The evolving role of enzalutamide on the treatment of prostate cancer
The field of prostate cancer has witnessed incredible progress in the last decade, owing to the approval of multiple survival-prolonging treatments for metastatic castration-resistant prostate cancer (mCRPC). Enzalutamide is a nonsteroidal androgen receptor inhibitor that targets multiple steps in t...
Na minha lista:
| Publicado no: | Future Oncol |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Future Medicine Ltd
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5551941/ https://ncbi.nlm.nih.gov/pubmed/26839021 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/fon.15.351 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|